These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 10212891)

  • 21. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
    Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
    Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimalarial drug resistance and combination chemotherapy.
    White N
    Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):739-49. PubMed ID: 10365399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of benzylamino and alkylamino ether analogues of artemisinin.
    O'Neill PM; Bishop LP; Storr RC; Hawley SR; Maggs JL; Ward SA; Park BK
    J Med Chem; 1996 Oct; 39(22):4511-4. PubMed ID: 8893847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artemisinin and its derivatives are transported by a vacuolar-network of Plasmodium falciparum and their anti-malarial activities are additive with toxic sphingolipid analogues that block the network.
    Akompong T; VanWye J; Ghori N; Haldar K
    Mol Biochem Parasitol; 1999 Jun; 101(1-2):71-9. PubMed ID: 10413044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A medicinal chemistry perspective on artemisinin and related endoperoxides.
    O'Neill PM; Posner GH
    J Med Chem; 2004 Jun; 47(12):2945-64. PubMed ID: 15163175
    [No Abstract]   [Full Text] [Related]  

  • 26. Delayed parasite clearance in a splenectomized patient with falciparum malaria who was treated with artemisinin derivatives.
    Le TA; Davis TM; Tran QB; Nguyen VP; Trinh KA
    Clin Infect Dis; 1997 Oct; 25(4):923-5. PubMed ID: 9356813
    [No Abstract]   [Full Text] [Related]  

  • 27. In vivo-in vitro model for the assessment of clinically relevant antimalarial cross-resistance.
    Noedl H; Wernsdorfer WH; Krudsood S; Wilairatana P; Viriyavejakul P; Kollaritsch H; Wiedermann G; Looareesuwan S
    Am J Trop Med Hyg; 2001 Dec; 65(6):696-9. PubMed ID: 11791959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artemisone--a highly active antimalarial drug of the artemisinin class.
    Haynes RK; Fugmann B; Stetter J; Rieckmann K; Heilmann HD; Chan HW; Cheung MK; Lam WL; Wong HN; Croft SL; Vivas L; Rattray L; Stewart L; Peters W; Robinson BL; Edstein MD; Kotecka B; Kyle DE; Beckermann B; Gerisch M; Radtke M; Schmuck G; Steinke W; Wollborn U; Schmeer K; Römer A
    Angew Chem Int Ed Engl; 2006 Mar; 45(13):2082-8. PubMed ID: 16444785
    [No Abstract]   [Full Text] [Related]  

  • 29. Structure-activity relationships of the antimalarial agent artemisinin. 7. Direct modification of (+)-artemisinin and in vivo antimalarial screening of new, potential preclinical antimalarial candidates.
    Avery MA; Alvim-Gaston M; Vroman JA; Wu B; Ager A; Peters W; Robinson BL; Charman W
    J Med Chem; 2002 Sep; 45(19):4321-35. PubMed ID: 12213073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artemisinin resistance: how can we find it?
    Noedl H
    Trends Parasitol; 2005 Sep; 21(9):404-5. PubMed ID: 16046187
    [No Abstract]   [Full Text] [Related]  

  • 31. Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors.
    Ittarat W; Pickard AL; Rattanasinganchan P; Wilairatana P; Looareesuwan S; Emery K; Low J; Udomsangpetch R; Meshnick SR
    Am J Trop Med Hyg; 2003 Feb; 68(2):147-52. PubMed ID: 12641403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress in the research of artemisinin-related antimalarials: an update.
    Woerdenbag HJ; Pras N; van Uden W; Wallaart TE; Beekman AC; Lugt CB
    Pharm World Sci; 1994 Aug; 16(4):169-80. PubMed ID: 7951130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New antimalarials. A risk-benefit analysis.
    Nosten F; Price RN
    Drug Saf; 1995 Apr; 12(4):264-73. PubMed ID: 7646825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artemisinin drugs: novel antimalarial agents.
    Price RN
    Expert Opin Investig Drugs; 2000 Aug; 9(8):1815-27. PubMed ID: 11060779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parasitology. A requiem for chloroquine.
    Hastings IM; Bray PG; Ward SA
    Science; 2002 Oct; 298(5591):74-5. PubMed ID: 12364772
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of pfcrt, pfmdr1, dhfr, and dhps mutations and drug sensitivities in Plasmodium falciparum isolates from patients in Vietnam before and after treatment with artemisinin.
    Ngo T; Duraisingh M; Reed M; Hipgrave D; Biggs B; Cowman AF
    Am J Trop Med Hyg; 2003 Mar; 68(3):350-6. PubMed ID: 12685644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mode of action of the antimalarial artemisinin and its derivatives.
    Kamchonwongpaisan S; Meshnick SR
    Gen Pharmacol; 1996 Jun; 27(4):587-92. PubMed ID: 8853288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artemisinin, a novel antimalarial drug: biochemical and molecular approaches for enhanced production.
    Abdin MZ; Israr M; Rehman RU; Jain SK
    Planta Med; 2003 Apr; 69(4):289-99. PubMed ID: 12709893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoperoxide-based compounds: cross-resistance with artemisinins and selection of a Plasmodium falciparum lineage with a K13 non-synonymous polymorphism.
    Paloque L; Witkowski B; Lelièvre J; Ouji M; Ben Haddou T; Ariey F; Robert A; Augereau JM; Ménard D; Meunier B; Benoit-Vical F
    J Antimicrob Chemother; 2018 Feb; 73(2):395-403. PubMed ID: 29177421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance.
    Krishna S; Woodrow CJ; Staines HM; Haynes RK; Mercereau-Puijalon O
    Trends Mol Med; 2006 May; 12(5):200-5. PubMed ID: 16616639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.